News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Risk Seen With Merck & Co., Inc. (MRK)-GlaxoSmithKline (GSK) Rotavirus Vaccines


1/14/2014 8:08:14 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Newer vaccines against rotavirus, a severe diarrheal disease in children, slightly raise the risk of a rare bowel problem that doomed an earlier vaccine, new studies show. But researchers say the modern vaccines are much safer and well worth this very small risk. Rotavirus kills more than 400,000 young children a year, mostly in poor countries.

Help employers find you! Check out all the jobs and post your resume.

Read at Washington Post
Read at NBC
Read at Bloomberg
Read at live science

comments powered by Disqus
   
Vaccine

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES